Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder

NCT02839200 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: ACT-541468 5 mg
DRUG: ACT-541468 10 mg
DRUG: ACT-541468 25 mg
DRUG: Zolpidem
DRUG: Placebo 1
DRUG: Placebo 2

Sponsor

Idorsia Pharmaceuticals Ltd.